To understand whether tumoral expression of leptin receptors regulated the growth of pancreatic cancers in the setting of obesity, we orthotopically injected pancreatic cancer cells in lean and obese mice utilizing interference RNA technology to deplete the leptin receptor from pancreatic cancer cells. This evidence concerns the gene LEPR and familial pancreatic carcinoma.